Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

315
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
315
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

301
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
301
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

293
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
293
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

308
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
308
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Homocysteine with Arterial Stiffness and Kidney Injury Biomarkers in Patients with Suspected Coronary Artery Disease.

Journal of clinical medicine·2026
Same authorSame journal

Filtering the 2026 ACC/AHA guidelines of dyslipidaemia management: what nephrologists need to know.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Endothelial dysfunction in human diabetic vascular complications: translating single-cell transcriptomics into therapeutic opportunities.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Iron excess is associated with atheroma presence and progression in chronic kidney disease in the NEFRONA cohort.

Scientific reports·2026
Same author

Randomized Cross-Over Trial of Electrolyte, Acid-Base and Blood Pressure Effects of Salt Supplements in CKD.

Kidney international reports·2026
Same author

Artificial intelligence in veterinary diagnostic imaging: A narrative review of the state of the art and its applications.

Veterinary journal (London, England : 1997)·2026

Related Experiment Video

Updated: Jan 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K

New kidneys, old risks: cardiovascular challenges after transplantation.

Amaryllis H Van Craenenbroeck1,2, Shanmugakumar Chinnappa3,4, Evangelia Dounousi5

  • 1Department of Nephrology, University Hospitals Leuven, Leuven, Belgium.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|November 9, 2025
PubMed
Summary

Kidney transplant recipients face high cardiovascular disease risks due to unique factors. More research is needed for tailored prevention and treatment strategies to improve long-term outcomes in these patients.

Keywords:
cardiovascular diseasekidney transplantationmanagement strategies

More Related Videos

Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

17.1K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.3K

Related Experiment Videos

Last Updated: Jan 11, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.9K
Murine Kidney Transplant Technique
08:58

Murine Kidney Transplant Technique

Published on: October 20, 2015

17.1K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

1.3K

Area of Science:

  • Nephrology
  • Cardiology
  • Immunology

Background:

  • Cardiovascular disease (CVD) is the primary cause of death in kidney transplant recipients (KTRs).
  • Kidney function restoration mitigates some risks but introduces new challenges like immunosuppression side effects, hypertension, and inflammation.
  • Existing risk tools inadequately address transplant-specific factors.

Purpose of the Study:

  • To review the complex cardiovascular risk factors in KTRs.
  • To highlight challenges in current management and identify areas for future research.
  • To emphasize the need for transplant-specific strategies and research.

Main Methods:

  • This is a review article, synthesizing existing literature on CVD in KTRs.
  • It analyzes traditional, transplant-specific, and donor/recipient-related risk factors.
  • It discusses current cardiovascular complications and management limitations.

Main Results:

  • KTRs experience high rates of coronary artery disease, heart failure, valvular disease, peripheral artery disease, and refractory hypertension.
  • Immunosuppression, persistent hypertension, post-transplant diabetes, and chronic inflammation contribute significantly to CVD burden.
  • Evidence for effective management is often extrapolated from non-transplant populations, with limited dedicated trials.

Conclusions:

  • There is an urgent need for transplant-specific cardiovascular research and personalized therapies.
  • Emerging treatments show promise but require validation in KTRs.
  • Addressing sex disparities and fostering multidisciplinary collaboration are crucial for optimizing outcomes.